Bafna Pharmaceuticals Limited
Share Price Target & Analysis
NSE:BAFNAPH
VWAP
Open
Close
High
Low
52 Week High
6.03 (4.95%)
BAFNAPH
(PHARMA)Turnaround Potential
52 Week Low
EPS
PE
PB
Economical
Quality
Gold
Valuation
#Analysis
NSE: BAFNAPH Share Price Financial Analysis & Valuation
Bafna Pharmaceuticals Limited (BAFNAPH) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical.
It is one of Micro Cap company with Market Capitalization of Rs 321.7 (in Cr). Total number of free float shares are 0 (in Lacs).
Bafna Pharmaceuticals Limited is listed on NSE with Exchange ID - INE878I01022 and trading code is NSE:BAFNAPH with short name Bafna Pharma.
In the past 1 year, Bafna Pharmaceuticals Limited has declared an equity dividend of Rs 0 per share. At the current share price of BAFNAPH at Rs 127.83, this results in a dividend yield of 0 %.
As per the Fundamental Analysis of NSE:BAFNAPH, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine BAFNAPH underlying value and future prospects. All of this data is available in BAFNAPH financial statements.
Quality of the Stock: As per the fundamental analysis of NSE:BAFNAPH, it is clearly understood that BAFNAPH is Economical performer in terms of earnings and profit margins with an EPS of 3.71. NSE:BAFNAPH book value per share as of today is 38.56. The current price to book ratio for BAFNAPH as of Mar 07, 2026 is 3.32.
Valuation of the Stock: The current valuation of BAFNAPH stock is like Gold which means currently the stock is Overpriced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of BAFNAPH whether to BUY this stock at current valuation. The delivery percentage of BAFNAPH is 0% is very crucial parameter which shows that 0% investors are anticipating that the price of BAFNAPH share should go up with VWAP at 127.85.
Now, the main question is whether to BUY or SELL, NSE:BAFNAPH at current valuation.
As per latest Analysis No. #1072:-
⇑ STRONG BUY BAFNAPH if All Greens
⇗ BUY BAFNAPH (at Lower Levels) if any 2 Greens
⇒ NEUTRAL or HOLD BAFNAPH (With Stop Loss) if only 1 Green
⇘ SELL BAFNAPH if NO Green Indicator
NSE: BAFNAPH Share Price Today (Mar 07, 2026)
(Bafna Pharmaceuticals Limited Daily Analysis on the basis of BAFNAPH Intraday Graph & Trend)
Bafna Pharmaceuticals Limited share price moved Up by 4.95% from its previous close of Rs 121.8. BAFNAPH stock last traded price is 127.83. BAFNAPH share price trend is Up with a total of 14136 stocks traded till now. It has touched an intraday high of Rs 127.89 and an intraday low of Rs 127.8. The BAFNAPH trading at 127.83, Up by Rs. 6.03, or 4.95 percent which suggests that most of the Traders are anticipating that the price of BAFNAPH share should go Up.
NSE: BAFNAPH Share Price Tomorrow Prediction
(Bafna Pharmaceuticals Limited Share Price Prediction for Tomorrow & future forecast is based on Current Trend of BAFNAPH)
Bafna Pharmaceuticals Limited share price moved Up by 4.95%. BAFNAPH share price short term trend is Up. It suggests that BAFNAPH Share Price for Tomorrow remains the same with VWAP at 127.85 will be treated as stop loss for intraday traders. Bafna Pharmaceuticals Limited Long term investors can follow the BAFNAPH long term trend as mentiond in future forecast table.
NSE Code |
NSE: BAFNAPH |
BAFNAPH Share Price Today |
127.83 |
BAFNAPH Share Price Target Prediction for 2026 ^ |
72.3 - 144.2 |
BAFNAPH Share Price Target Prediction for 2027*^ |
144.2 - 216.3 |
BAFNAPH Share Price Target Prediction for 2028*^ |
216.3 - 231.4 |
BAFNAPH Share Price Target Prediction for 2029*^ |
243 |
BAFNAPH Share Price Target Prediction for 2030*^ |
250 |
BAFNAPH Share Price Target Prediction for 2035*^ |
272 |
| BAFNAPH Current Book Value 2025 |
38.4 |
*Bafna Pharmaceuticals Limited Short Term & Long Term share price target is based on current financial year earings of the company.
^BAFNAPH share price target prediction for 2025 2026 2027 to 2030 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.
BAFNAPH Technical Analysis
Candlestick Pattern: @83.37| MA | Simple | Action S1 | Expo | Action E2 |
|---|---|---|---|---|
| MA_5 | 85.09 | SELL | 84.91 | SELL |
| MA_12 | 84.94 | SELL | 84.07 | SELL |
| MA_20 | 81.67 | BUY | 82.58 | BUY |
| MA_32 | 78.67 | BUY | 80.53 | BUY |
| MA_50 | 77.39 | BUY | 79.34 | BUY |
| MA_100 | 77.31 | BUY | 78.45 | BUY |
| MA_200 | 78.92 | BUY | 79.65 | BUY |
| Trend Oscillators | Value | Action |
|---|---|---|
| Bollinger Bands | 81.67 | Uptrend |
| MACD | -0.05 | SELL |
| ADX | 28.23 | Strong Trend |
| DMI (+/-) | 23.65 / 17.77 | Uptrend |
| Momentum Oscillators | Value | Action |
|---|---|---|
| RSI | 55.21 | Neutral |
| STOCHASTIC_K (Fast) | 20.56 | Neutral |
| STOCHASTIC_D (Slow) | 21.55 | Neutral |
| CCI | -7.31 | Neutral |
| PSAR | 93.7 | SELL |
| TRUE RANGE | 3.16 | SELL |
| ATR | 3.92 | SELL |
| WILLIAMS R | -58.13 | Neutral |
| TRIX | 0 | Neutral |
| STOCHASTIC RSI K | 0 | Oversold |
| STOCHASTIC RSI D | 0 | Oversold |
| MOMENTUM | 10.25 | BUY |
| Duration | Value |
|---|---|
| 1 Year | -3.54% |
| 3 Months | 14.21% |
| 1 Month | 14.02% |
| 1 Week | -6.55% |
| Action | Overall (%) |
|---|---|
| BUY | 47% |
| NEUTRAL / HOLD | 20% |
| SELL | 33% |
Most popular Questions & Answers about BAFNAPH
Bafna Pharmaceuticals Limited stock last traded price is 127.83. BAFNAPH share price moved Up by 4.95% from its previous close of Rs 121.8.
Bafna Pharmaceuticals Limited share price trend is Up with a total of 14136 stocks traded till now. It has touched an intraday high of Rs 204.0806 and an intraday low of Rs 127.8. The BAFNAPH trading at 127.83, Up by Rs. 6.03, or 4.95 percent which suggests that most of the Traders are anticipating that the price of BAFNAPH share should go Up and the Stop Loss will be around 127.85.
The market cap of Bafna Pharmaceuticals Limited is ₹321.7 (in Cr) as of Mar 06, 2026.
The current price to earning ratio for Bafna Pharmaceuticals Limited as of Mar 06, 2026 is 39.13.
The current price to book ratio for Bafna Pharmaceuticals Limited as of Mar 06, 2026 is 3.32.
The highest price of Bafna Pharmaceuticals Limited stock is ₹202.06 in the last 52-week.
The lowest price of Bafna Pharmaceuticals Limited stock is ₹69 in the last 52-week.
Bafna Pharmaceuticals Limited share trading at ₹127.83, Up by Rs. 6.03, or 4.95 percent which suggests that most of the traders are anticipating that the price of BAFNAPH share should go Up.
In 2025, Stock price target for Bafna Pharmaceuticals Limited (BAFNAPH) are ₹72.3 on downside and ₹144.2 on upside. Bafna Pharmaceuticals Limited share price target is based on current financial year earings of the company.
In 2026, Stock price target for Bafna Pharmaceuticals Limited (BAFNAPH) are ₹144.2 on downside and ₹216.3 on upside. Bafna Pharmaceuticals Limited share price target is based on forecasted future earnings of the company.
In 2027, Stock price target for Bafna Pharmaceuticals Limited (BAFNAPH) are ₹216.3 on downside and ₹231.4 on upside. Bafna Pharmaceuticals Limited share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.
In next five years, Stock price target for Bafna Pharmaceuticals Limited (BAFNAPH) will be around ₹250 Bafna Pharmaceuticals Limited share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of BAFNAPH.
The price of Bafna Pharmaceuticals Limited (BAFNAPH) shares moved by 4.95%. The short-term trend for BAFNAPH share price is Up. It implies that the share price of BAFNAPH will stay the same tomorrow and that intraday traders should treat VWAP at 127.85 as a stop loss. Investors with a long-term outlook can track BAFNAPH long-term trajectory, which is indicated in the future forecast table.
Estimated DCF Value of BAFNAPH stock is 44.5. Compared to the current market price of 127.83 INR, the BAFNAPH stock is Overvalued by 65.2%.
As per the fundamental analysis of Bafna Pharmaceuticals Limited (BAFNAPH), it is of Economical quality in terms of earnings and profit margins with an EPS of 3.71. Bafna Pharmaceuticals Limited book value per share as of today is 38.56. The current price to book ratio for BAFNAPH as of Mar 07, 2026 is 3.32.
NSE:BAFNAPH News & Other Useful Information about BAFNAPH Share Price
Peer Comparison of NSE: BAFNAPH
The Peers list includes companies operating in the same industry and having comparable market cap.
Sector: Pharmaceuticals
| Company | Price | EPS | BV |
|---|---|---|---|
| SUNPHARMA | 1714.80 | 16.77 | 99.25 |
| DIVISLAB | 6196.50 | 94.7 | 578.26 |
| MEDICAMEQ | 363.95 | 6.47 | 200.56 |
| CIPLA | 1353.20 | 57.14 | 411.56 |
| DRREDDY | 1281.00 | 55.59 | 377.56 |
| PGHH | 5215.00 | 189.8 | 373.34 |
| TORNTPHARM | 4032.00 | 62.26 | 249.83 |
| BIOCON | 374.75 | 4.12 | 99.48 |
| LUPIN | 2225.70 | 126.08 | 595.77 |
| ALKEM | 5775.00 | 204.32 | 1142.87 |